ID12241161 / Ildong - LARVOL DELTA

Discovery of ID12241161, an oral KRASmulti inhibitor demonstrating potent and selective anti-cancer effects in KRAS-dependent cancers (AACR 2025) - "Our data indicated that ID12241161 possesses potent anticancer effects in KRAS-dependent cancers, with a wide safety margin and favorable pharmacokinetics, allowing for once-daily dosing. These findings support the potential use of ID12241161 as a viable treatment option for patients with KRAS-driven cancers."

Colorectal Cancer • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Sarcoma • Solid Tumor • KRAS